share_log

Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $27

Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $27

Truist证券继续买入Privia Health Gr,将价格目标上调至27美元
Benzinga ·  2024/11/08 10:02  · 评级/大行评级

Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $24 to $27.

Truist Securities的分析师 Jailendra Singh 维持对Privia Health Gr(纳斯达克:PRVA)的买入评级,并将目标股价从24美元上调至27美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发